Publications

Show Filters

Searches all publications.

Search Term

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-02-20
    E.g., 2018-02-20

Articles

254480 items
12:00 AM, Aug 15, 1994  |  BC Week In Review | Company News  |  Other News

Escagenetics news

With cash and cash equivalents of $730,000 as of June 30, the San Carlos, Calif., said its senior executives are working without compensation and employee salaries have been cut 20 percent. ESN, which declined to...
12:00 AM, Aug 15, 1994  |  BC Week In Review | Clinical News  |  Preclinical Results

Agouron preclinical data

AGPH reported preclinical data in Yokohama, showing that its synthetic inhibitor of HIV protease can stop replication of the virus, including clinical and drug-resistant strains, and demonstrating oral bioavailability in four species of test animals....
12:00 AM, Aug 15, 1994  |  BC Week In Review | Company News  |  Other News

California Institute of Technology other research news

CalTech scientists have reported a method for synthesizing the asymmetric, anti-inflammatory drug naproxen. As described in Nature, the CalTech procedure has potential to meet commercial needs. The proportion of the desired chiral product was 96...
12:00 AM, Aug 15, 1994  |  BC Week In Review | Clinical News  |  Clinical Results

MS-264 and MS-264 MRI contrast agents data

The Cambridge, Mass. company presented animal data showing improved magnetic resonance imaging of liver and breast tumors by the gadolinium-bearing compounds. At the Conference of the Society of Magnetic Resonance in San Francisco, the...
12:00 AM, Aug 15, 1994  |  BioCentury | Analyst Picks & Changes

Analyst picks & changes

Biogen Inc. (BGEN) Based on information released so far, Lind & Co. analyst Douglas Lind projects the company's 1997 beta interferon revenues at $200-300 million. If data from the company's Phase III multiple sclerosis...
12:00 AM, Aug 15, 1994  |  BC Week In Review | Company News  |  Other News

Pharmacyclics other research news

The Sunnyvale, Calif., company and university collaborators described new technology for antisense compounds in the Journal of the American Chemical Society. Pharmacyclics described site-specific cutting of RNA with a ribozyme analog made of a porphyrin-like...
12:00 AM, Aug 15, 1994  |  BC Week In Review | Company News  |  Deals

Connective Therapeutics, Genentech deal

Connective Therapeutics Inc.   Genentech Inc. (GNE)   Connective obtained expanded rights to Relaxin, a natural hormone that regulates connective tissue remodeling. Under the revised agreement with GNE, Connective received worldwide rights excluding Japan, the Republic...
12:00 AM, Aug 15, 1994  |  BC Week In Review | Company News  |  Deals

Ecogen deal

EECN expects its Cutlass, Condor and Foil Bacillus thuringiensis products to be commercialized first, initially to protect vegetable crops against caterpillar pests. Ecogen Inc. (EECN)   EECN (Langhorne, Penn.) expanded its agreement with Nissan Chemical...
12:00 AM, Aug 15, 1994  |  BC Week In Review | Clinical News  |  Clinical Results

HIV urine test data

The Berkeley, Calif., company's urine test for HIV identified the viral antibodies in all 233 HIV-positive test cases in an Asian study reported by the Japanese NIH. The test is being reviewed for approval by...
12:00 AM, Aug 15, 1994  |  BC Week In Review | Company News  |  Deals

Innovir deal

APL is linked to a genetic anomaly, chromosomal translocation, that leads to the over-production of abnormal immature white blood cells called promyelocytes, which fail to mature into normal white blood cells. Conventional treatments involve chemotherapy,...

Pages